Clinical Trials Browser

Phase 2/3 × Overweight × Megestrol Acetate × Clear all

NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2/3 Recruiting

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight